Compare Humana Inc (HUM) vs SkyWest Inc (SKYW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs SkyWest Inc — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while SkyWest Inc trades at $96.42 (market cap $3.76B). The key difference: Humana Inc is far larger — about 12.7× SkyWest Inc's market cap, and Humana Inc pays a 0.89% dividend while SkyWest Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and SkyWest Inc for 8 Days on average.
| HUM | SKYW | |
|---|---|---|
Market Cap | $47.61B | $3.76B |
Volume | 1,827,332 | 296,298 |
Sector | Health | Industrials |
52-Week High | $409.85 | $115.94 |
52-Week Low | $163.67 | $78.40 |
Typical Hold Time | 53 Days | 8 Days |
Enterprise Value | $54.97B | $5.54B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
SkyWest (SKYW) trades at $96.64, down 1.1% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported mixed earnings, beating in Q1 2026 but missing in Q4 2025 and Q2 2026, with revenue growth from $4.1B in 2025 to $4.2B in 2026. Analyst consensus is bullish with a $112 price target, supported by fleet upgrades and flying agreements, though net income margin dipped to 9.78% in 2026.
The outlook is cautiously optimistic given strong analyst buy ratings and undervalued metrics like a P/E of 9.6, but risks include cost pressures, insider selling, and technical bearishness. Upside hinges on execution of growth initiatives amid competitive and operational headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About SkyWest Inc
SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →
